By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Nanosphere reported after the close of the market Thursday that its second-quarter revenues increased around 28 percent, but its net loss jumped 64 percent on higher spending.

The Northbrook, Ill.-based molecular diagnostics firm brought in total revenues of $516,803 for the three-month period ended June 30, up from $402,237 for the second quarter of 2009. It fell short of analysts' consensus estimate for revenues of $880,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.